Medicenna Therapeutics to Present at Upcoming March Investor Conferences

NEXT STORY
Apollomics, Inc. Announces Successful Enrollment of First Patient Into Phase 1 Clinical Trial of APL-106 (Uproleselan Injection) in China
PREV STORY
Sotherly Hotels Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Medical Device Testing Market to Reach $12.5 Billion by 2027, Growing at a CAGR of 4.7% From 2020 With COVID-19 Impact – Meticulous Research® Analysis

author_avatar
NASDAQ Market News

Meharry Medical College, Morehouse School of Medicine Partner with University of Zambia to Enhance Global Health Education and Research

author_avatar
NASDAQ Market News

Syneos Health Releases 2022 Dealmakers’ Intentions Survey

author_avatar
NASDAQ Market News